Tech Company Financing Transactions
Amaranth Medical Funding Round
DCP Management, Bio*One Capital and CLS participated in a $20 million Series B funding round for Amaranth Medical. The round was announced by the company on 10/9/2013.
Transaction Overview
Company Name
Announced On
10/9/2013
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds from this financing will support continued development and the upcoming CE Mark clinical trial of FORTITUDE, a bioresorbable scaffold for use in treating coronary artery disease.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1145 Terra Bella Ave.
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Overview
Amaranth Medical was originally incorporated in 2005 to commercialize the research of Professors Freddy Boey and Subbu Venkatraman at the School of Materials Science and Engineering, Nanyang Technological University. The company has developed a stent for use in ameliorating blockage of theureter caused by diseases of the urinary tract.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kamal Ramzipoor
VP - R & D
Anthony Andreacchi
VP - Regulatory Affairs
Jane Beggs
Browse more venture capital transactions:
Prev: 10/9/2013: Nuventix venture capital transaction
Next: 10/9/2013: Socratic venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. All VC database entries on this site are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs